MedEX: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MedEX
Largest movements
- Cash +€6,540
up €6,540 (+81.5%), from €8,027 to €14,568
mainly Debts after one year (+€67,654) and Other debts (+€15,164)
- Intangible fixed assets +€1,995
new in 2025: €1,995
- Deferred charges and accrued income +€1,367
up €1,367 (+492.2%), from €278 to €1,645
- Receivables within one year -€785
down €785 (-24.6%), from €3,186 to €2,401
- Profit (loss) carried forward -€78,042
down €78,042 (-59.8%), from -€130,497 to -€208,539
- Debts after one year +€67,654
up €67,654 (+81.7%), from €82,771 to €150,425
- Other debts +€15,164
up €15,164 (+233.3%), from €6,500 to €21,664
- Accrued charges and deferred income +€2,398
up €2,398 (+52.1%), from €4,606 to €7,004
- Trade debts +€1,944
up €1,944 (+24.0%), from €8,112 to €10,056
- Gross operating margin -€39,506
down €39,506 (-135.5%), from -€29,164 to -€68,670
- Financial charges +€2,768
up €2,768 (+57.9%), from €4,781 to €7,549
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €11,491 | €20,609 | +€9,118 | +79.3% |
| Fixed assets | 21/28 | - | €1,995 | +€1,995 | |
| Intangible fixed assets | 21 | - | €1,995 | +€1,995 | |
| Current assets | 29/58 | €11,491 | €18,614 | +€7,123 | +62.0% |
| Amounts receivable within one year | 40/41 | €3,186 | €2,401 | -€785 | -24.6% |
| Other amounts receivable | 41 | €3,186 | €2,401 | -€785 | -24.6% |
| Cash at bank and in hand | 54/58 | €8,027 | €14,568 | +€6,540 | +81.5% |
| Deferred charges and accrued income | 490/1 | €278 | €1,645 | +€1,367 | +492.2% |
| Total equity and liabilities | 10/49 | €11,491 | €20,609 | +€9,118 | +79.3% |
| Equity | 10/15 | -€90,497 | -€168,539 | -€78,042 | -86.2% |
| Contributions | 10/11 | €40,000 | €40,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€130,497 | -€208,539 | -€78,042 | -59.8% |
| Amounts payable | 17/49 | €101,988 | €189,148 | +€87,160 | +85.5% |
| Amounts payable after more than one year | 17 | €82,771 | €150,425 | +€67,654 | +81.7% |
| Financial debts | 170/4 | €82,771 | €150,425 | +€67,654 | +81.7% |
| Amounts payable within one year | 42/48 | €14,612 | €31,720 | +€17,108 | +117.1% |
| Trade debts | 44 | €8,112 | €10,056 | +€1,944 | +24.0% |
| Suppliers | 440/4 | €8,112 | €10,056 | +€1,944 | +24.0% |
| Other amounts payable | 47/48 | €6,500 | €21,664 | +€15,164 | +233.3% |
| Accrued charges and deferred income | 492/3 | €4,606 | €7,004 | +€2,398 | +52.1% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | - | €6 | +€6 | |
| Other operating charges | 640/8 | €1,584 | €1,817 | +€233 | +14.7% |
| Gross operating margin | 9900 | -€29,164 | -€68,670 | -€39,506 | -135.5% |
| Operating profit (loss) | 9901 | -€30,748 | -€70,493 | -€39,745 | -129.3% |
| Financial income | 75/76B | €0 | - | -€0 | |
| Recurring financial income | 75 | €0 | - | -€0 | |
| Financial charges | 65/66B | €4,781 | €7,549 | +€2,768 | +57.9% |
| Recurring financial charges | 65 | €4,781 | €7,549 | +€2,768 | +57.9% |
| Profit (loss) for the period before taxes | 9903 | -€35,529 | -€78,042 | -€42,513 | -119.7% |
| Profit (loss) for the period | 9904 | -€35,529 | -€78,042 | -€42,513 | -119.7% |
| Profit (loss) for the period to be appropriated | 9905 | -€35,529 | -€78,042 | -€42,513 | -119.7% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 5 October 2026 via checked.be.